Indocyanine Green Marking of Axillary Sentinel Lymph Nodes in Early Breast Cancer
Geburtshilfe und Frauenheilkunde · 2025-06 · 85 (06) · 631-638
DOI: 10.1055/a-2436-1699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, online erschienen am 12.11.2024. Verfasst von Steffi Hartmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Axillary sentinel lymph node excision (SLNE) in breast cancer patients with clinically node-negative disease may be carried out using different tracers. The standard tracer is technetium colloid (99mTc). Indocyanine green (ICG) can be used as an alternative. This study aimed to evaluate the clinical usefulness of this fluorescent dye in a standardized setting. A prospective, single-center cohort study carried out at the University Gynecological Hospital of Rostock from September 2023 to May 2024 carried out sentinel lymph node marking using only ICG in patients with breast malignancies. The ICG injection was administered immediately after the induction of anesthesia. Detection of the sentinel lymph node (SLN) was done using a laparoscopy system suitable for ICG. The aim was to determine the detection rate (DR) for SLNs marked exclusively using ICG and to record any complications. The costs of using ICG to mark SLNs were compared with those for 99mTc marking. During the study period, contraindications against marking with ICG were ascertained for five (3.8%) of 132 patients with planned SLNE. A total of 100 SLNEs were carried out after ICG marking in patients who met the inclusion criteria in the context of the study. A median of two SLNs were resected. The detection rate (DR) for SLNs was 98.0%. SLNs were identified in all obese patients. No serious systemic side effects occurred following ICG injection. Transient skin discoloration in the area around the injection site were observed in eight patients. The direct cost of ICG marking was 62.73 Euros, which was 170.36 Euros lower than the cost of 99mTc marking. The detection rate of axillary SLNs marked using ICG is high and the method is cost-effective, has few side effects and can also be used in obese patients. Contraindications against the administration of ICG are rare. Marking with ICG is a good alternative to the 99mTc method and offers advantages in terms of costs, logistics, no exposure to radiation, and patient comfort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universitätsfrauenklinik und Poliklinik, Klinikum Südstadt, Rostock, Germany.
- Diagnostische und interventionelle Radiologie, Klinikum Südstadt, Rostock, Germany.
Zitieren
APA
Hartmann, S., Plonus, M. L., Schultek, G., Stubert, J., Gerber, B., & Reimer, T. (2025). Indocyanine Green Marking of Axillary Sentinel Lymph Nodes in Early Breast Cancer. Geburtshilfe und Frauenheilkunde, 85(06), 631-638. https://doi.org/10.1055/a-2436-1699
Vancouver
Hartmann S, Plonus ML, Schultek G, Stubert J, Gerber B, Reimer T. Indocyanine Green Marking of Axillary Sentinel Lymph Nodes in Early Breast Cancer. Geburtshilfe und Frauenheilkunde. 2025;85(06):631-638. doi:10.1055/a-2436-1699
BibTeX
@article{Hartmann2025,
author = {Hartmann, Steffi and Plonus, Meri-Liis and Schultek, Gesche and Stubert, Johannes and Gerber, Bernd and Reimer, Toralf},
title = {Indocyanine Green Marking of Axillary Sentinel Lymph Nodes in Early Breast Cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2025},
volume = {85},
number = {06},
pages = {631--638},
doi = {10.1055/a-2436-1699}
}
EUVIMED